Register entry
QOL MEDICAL
- Registered sites
- 1
- Drug products
- 2
- Live patents
- 7
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| QOL Medical, LLC | CLEARWATER, FLUnited States | Analytical testing, Active ingredient (API) manufacture | 3014492051 |
Exclusivity
Patents
7Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | Dec 2029 |
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | May 2030 |
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | Nov 2038 |
Catalogue
Marketed products
2Showing 2 of 2.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Ethamolin | Ethanolamine Oleate | INJECTION, SOLUTION | NDA |
| Sucraid | sacrosidase | SOLUTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.